A detailed history of Bryn Mawr Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 3,686 shares of EW stock, worth $252,601. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,686
Previous 3,359 9.74%
Holding current value
$252,601
Previous $320,000 6.25%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $27,566 - $30,839
327 Added 9.74%
3,686 $340,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $25,751 - $33,923
-355 Reduced 9.56%
3,359 $320,000
Q3 2023

Nov 15, 2023

BUY
$69.28 - $93.38 $8,937 - $12,046
129 Added 3.6%
3,714 $257,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $3,935 - $4,479
-53 Reduced 1.46%
3,585 $296,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $4,365 - $5,686
53 Added 1.48%
3,638 $300,000
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $1,124 - $1,667
-13 Reduced 0.36%
3,585 $341,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $209,323 - $263,482
-2,053 Reduced 36.33%
3,598 $424,000
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $229,546 - $282,007
-2,158 Reduced 27.63%
5,651 $732,000
Q3 2021

Oct 26, 2021

SELL
$102.91 - $122.75 $42,398 - $50,573
-412 Reduced 5.01%
7,809 $884,000
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $4,192 - $5,238
-50 Reduced 0.6%
8,221 $852,000
Q1 2021

Apr 23, 2021

SELL
$78.68 - $90.67 $6,294 - $7,253
-80 Reduced 0.96%
8,271 $692,000
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $2,867 - $3,649
-40 Reduced 0.48%
8,351 $761,000
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $79,821 - $103,878
1,188 Added 16.49%
8,391 $670,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $267,043 - $357,124
4,641 Added 181.15%
7,203 $497,000
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $18,657 - $28,836
-356 Reduced 12.2%
2,562 $483,000
Q4 2019

Feb 11, 2020

BUY
$71.7 - $82.09 $2,724 - $3,119
38 Added 1.32%
2,918 $680,000
Q3 2019

Oct 24, 2019

SELL
$61.55 - $75.43 $7,693 - $9,428
-125 Reduced 4.16%
2,880 $634,000
Q2 2019

Aug 15, 2019

BUY
$55.74 - $64.41 $23,689 - $27,374
425 Added 16.47%
3,005 $555,000
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $95 - $128
2 Added 0.08%
2,580 $494,000
Q3 2018

Nov 15, 2018

SELL
$45.7 - $58.03 $914 - $1,160
-20 Reduced 0.77%
2,578 $449,000
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $3,905 - $4,719
92 Added 3.67%
2,598 $378,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $5,206 - $6,643
-140 Reduced 5.29%
2,506 $350,000
Q4 2017

Feb 15, 2018

BUY
$33.79 - $39.39 $89,408 - $104,225
2,646
2,646 $298,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.